118 related articles for article (PubMed ID: 10072413)
1. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants.
Muennig P; Pallin D; Sell RL; Chan MS
N Engl J Med; 1999 Mar; 340(10):773-9. PubMed ID: 10072413
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening and correcting refractive errors in school children in Africa, Asia, America and Europe.
Baltussen R; Naus J; Limburg H
Health Policy; 2009 Feb; 89(2):201-15. PubMed ID: 18621429
[TBL] [Abstract][Full Text] [Related]
3. Economic Analysis of the Impact of Overseas and Domestic Treatment and Screening Options for Intestinal Helminth Infection among US-Bound Refugees from Asia.
Maskery B; Coleman MS; Weinberg M; Zhou W; Rotz L; Klosovsky A; Cantey PT; Fox LM; Cetron MS; Stauffer WM
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004910. PubMed ID: 27509077
[TBL] [Abstract][Full Text] [Related]
4. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States.
Khan K; Muennig P; Behta M; Zivin JG
N Engl J Med; 2002 Dec; 347(23):1850-9. PubMed ID: 12466510
[TBL] [Abstract][Full Text] [Related]
5. Treatment of intestinal parasites in immigrants.
Geltman P; Meyers A
N Engl J Med; 1999 Jul; 341(5):377-8. PubMed ID: 10428671
[No Abstract] [Full Text] [Related]
6. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States.
Muennig P; Pallin D; Challah C; Khan K
Epidemiol Infect; 2004 Dec; 132(6):1055-63. PubMed ID: 15635962
[TBL] [Abstract][Full Text] [Related]
7. Albendazole therapy and enteric parasites in United States-bound refugees.
Swanson SJ; Phares CR; Mamo B; Smith KE; Cetron MS; Stauffer WM
N Engl J Med; 2012 Apr; 366(16):1498-507. PubMed ID: 22512482
[TBL] [Abstract][Full Text] [Related]
8. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
Murray J; McFarland DA; Waldman RJ
Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
[TBL] [Abstract][Full Text] [Related]
13. Mathematical models of cervical cancer prevention in the Asia Pacific region.
Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
[TBL] [Abstract][Full Text] [Related]
14. Enteric parasites in east African immigrants. Symptoms and duration of U.S. residence are not predictive.
Sachs WJ; Adair R; Kirchner V
Minn Med; 2000 Dec; 83(12):25-8. PubMed ID: 11147284
[TBL] [Abstract][Full Text] [Related]
15. A study of the cost effectiveness of selective health interventions for the control of intestinal parasites in rural Bangladesh.
Mascie-Taylor CG; Alam M; Montanari RM; Karim R; Ahmed T; Karim E; Akhtar S
J Parasitol; 1999 Feb; 85(1):6-11. PubMed ID: 10207355
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
Blake DR; Gaydos CA; Quinn TC
Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
[TBL] [Abstract][Full Text] [Related]
17. Who should be screened for HIV infection? A cost-effectiveness analysis.
McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
[TBL] [Abstract][Full Text] [Related]
18. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
Chisholm D;
Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443
[TBL] [Abstract][Full Text] [Related]
20. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
